Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |